Filing Details

Accession Number:
0001077183-25-000096
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-05-08 16:13:18
Reporting Period:
2025-05-06
Filing Date:
2025-05-08
Accepted Time:
2025-05-08 16:13:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1077183 Neogenomics Inc NEO Services-Testing Laboratories (8734) 742897368
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1582393 P. Anthony Zook 9490 Neogenomics Way
Fort Myers FL 33912
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-05-06 18,900 $7.88 18,900 No 4 P Indirect Amended and Restated Anthony P. Zook Living Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Amended and Restated Anthony P. Zook Living Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 11,336 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $14.82 2024-08-10 2033-08-10 8,353 8,353 Direct
Common Stock Stock Option (Right to Buy) $13.71 2025-06-01 2034-06-01 8,672 8,672 Direct
Common Stock Restricted Stock Unit $0.00 2025-06-01 12,254 12,254 Direct
Common Stock Stock Option (Right to Buy) $10.44 2035-04-01 729,927 729,927 Direct
Common Stock Restricted Stock Unit $0.00 421,496 421,496 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2033-08-10 8,353 8,353 Direct
2034-06-01 8,672 8,672 Direct
12,254 12,254 Direct
2035-04-01 729,927 729,927 Direct
421,496 421,496 Direct
Footnotes
  1. Once vested, the shares of common stock are not subject to expiration.
  2. This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on April 1, 2025 and multiplied by 110%.
  3. On April 1, 2025, Mr. Zook was granted 729,927 stock options. The options vest ratably over the first three anniversary dates of the grant date.
  4. On April 1, 2025, Mr. Zook was granted 421,496 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.